DAILY EQUITY REPORT BY EPIC RESEARCH- 19 NOVEMBER 2012
Upcoming SlideShare
Loading in...5
×
 

DAILY EQUITY REPORT BY EPIC RESEARCH- 19 NOVEMBER 2012

on

  • 197 views

Epic Research is a leading financial services provider with presence in Indian and other global capital markets. Provides Stock Tips, Forex Tips, Currency Tips, Commodity Tips, MCX Tips, Equity Tips, ...

Epic Research is a leading financial services provider with presence in Indian and other global capital markets. Provides Stock Tips, Forex Tips, Currency Tips, Commodity Tips, MCX Tips, Equity Tips, Tips, Intraday Tips, NSE Tips, BSE Tips, COMEX Tips, PCG Pack NCDEX Tips and Free Stock Tips. We provide services in equity, commodity and Forex market.

Statistics

Views

Total Views
197
Views on SlideShare
197
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

DAILY EQUITY REPORT BY EPIC RESEARCH- 19 NOVEMBER 2012 DAILY EQUITY REPORT BY EPIC RESEARCH- 19 NOVEMBER 2012 Document Transcript

  • HEADLINES  Indian Market Indian equity markets down by 1.01%. Nifty down by 56.95 pts and settle at 5574.05 Sensex down by 162.00 pts at 18309.37. Bank Nifty down by 185.90 pts at 11335.50 DAILY EQUITY  Global Market NEWSLETTER European markets were down with FTSE TH down by 35.24 pts at 5642.51,CAC down 19 NOVEMBER 2012 by 10.84 pts at 3371.56 and DAX down by 40.39 pts at 7003.03 Dow future down by 34.00 pts at  HEADLINES 12488.00• SREI likely to launch infra debt fund by January 2013• Inflation still high, says RBI governor• Biocon in pact with Bristol-Myers for blockbuster drug• Govt seeking support of political parties for imp bills: FM WWW.EPICRESEARCH.CO 09752199966
  •  MARKET ANALYSIS:  Key benchmark indices slumped in late trade as European stocks edged lower and as trading in US index futures indicated lower opening of US stocks later in the global day today, 16 November 2012.  The BSE Sensex was down 201.99 points or 1.09% to 18,269.38.  The S&P CNX Nifty was down 68.80 points or 1.22% to 5,562.20, as per provisional figures.  From the 30-share Sensex pack, 25 stocks fell while the rest of them rose.  Realty stocks edged lower. HDIL, D B Realty, Unitech and Sobha Developers fell by between 2.47% to 7.05%. Bank stocks fell across the board. Private sector banking giant ICICI Bank fell 2.93%. State Bank of India (SBI) declined 2.26%. SBIs net profit rose 30.16% to Rs 3658.14 crore on 12.21% increase in total income to Rs 32983.47 crore in Q2 September 2012 over Q2 September 2011. Among other PSU bank stocks, Canara Bank, Union Bank of India, Bank of India, Bank of Baroda and Punjab National Bank shed by between 1.29% to 3.71%. STOCKS TO WATCH  FII’s and DII’s  INFOSYSCATEGORY DATE BUY SELL NET  AMBUJA FII 16-Nov-12 2992.05 2482.34 509.7  ARVIND  HDIL DII 16-Nov-12 919.18 1293.9 -374.72 SCRIPS IN BAN PERIOD  NIFTY DAILY PIVOTS  SUZLONPIVOT R4 R3 R2 R1 PP S1 S2 S3 S4NIFTY 5867 5776 5685 5629 5594 5538 5503 5412 5321  HDIL WWW.EPICRESEARCH.CO 09752199966
  • .  GAINERS AND LOOSERS EXPERT OPINION NIFTY DAILY NIFTY GAINERS  Nifty looks SidewaysSCRIPS RATE VOL. PR. NET %  Strategy: Buy on dips (000) CLOSE CHAN CHANG GE E  Support:5530 Bharti 301.40 11860.20 290.30 11.10 3.82  Resistance: 5610 Airtel Dr BANK NIFTYReddys 1756.90 430.23 1721.65 35.25 2.05 Lab  Bank Nifty looks Sideways Infosys 2343.35 1711.64 2296.30 47.05 2.05  Strategy: Buy on dips  Support:11260 ONGC 257.90 4009.47 253.50 4.40 1.74  Resistance:11410 Jindal 371.10 2825.97 368.10 3.00 0.81 Steel  PREVIOUS PERFORMANCE DAILY NIFTY LOOSERS TYPE SCRIP B/S RESULTSCRIPS RATE VOL. PR. NET % TGT CASH COAL INDIA B (000) CLOSE CHAN CHA ACHEIVED GE NGE TGT CASH BIOCON B ACHEIVED IDFC 159.35 4653.45 164.90 -5.55 -3.37 TGT FUTURE JINDAL S ACHEIVED DLF 203.60 6964.77 209.25 -5.65 -2.70 TGT FUTURE BPCL S ACHEIVED PNB 742.90 379.84 763.25 -20.35 -2.67 Tata 265.00 7322.12 272.25 -7.25 -2.66 Motors ICICI 1027.30 2380.46 1054.65 -27.35 -2.59 Bank 09752199966
  • MARKET CALLS CASH ST ND SCRIPS ACTION LEVEL 1 TARGET 2 TARGET STOP LOSS AUROBINDO BUY 177.00 178.00 179.00 175.50 PHARMA CENTURY TEXTILE BUY 395.00 397.00 399.00 392.00 FUTURE ST ND SCRIPS ACTION LEVEL 1 TARGET 2 TARGET STOP LOSS. GODREJ SELL 301.00 299.00 297.00 304.00 JINDAL STEEL BUY 372.00 376.00 380.00 366.00 Disclaimer The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE. The share price projections shown are not necessarily indicative of future price performance. The information herein, togethe r with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer. All Rights Reserved. Investment in equity & bullion market has its own risks. We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.